Category: Cell therapy

Lantidra is the first FDA-approved allogeneic pancreatic islet cellular therapy for Type 1 diabetes patients with frequent, severe hypoglycemia. While it represents a groundbreaking treatment option, it is not a cure and is only available to a select group of adults who meet very specific medical criteria.

An estimated 1.4 million Americans have Type 1 diabetes, but only a small subset experiencing severe hypoglycemia and unawareness may be eligible for the innovative cell therapy, Lantidra. If you're asking, **'Can I get lantidra?'**, the answer involves navigating a highly specialized and restrictive process that depends on very specific medical qualifications.